Table 7.
Cox Proportional Hazards Analysis for MACE After Discharge
| Univariable |
Multivariable |
|||
|---|---|---|---|---|
| HR (95% CI) | P Value | HR (95% CI) | P Value | |
| Age, y | 1.03 (1.02-1.05) | <0.001 | 1.03 (1.02-1.05) | <0.001 |
| Men | 1.00 (0.72-1.39) | >0.99 | 1.18 (0.84-1.65) | 0.34 |
| Cardiogenic shock | 1.16 (0.77-1.77) | 0.48 | 1.12 (0.73-1.72) | 0.59 |
| Drug-eluting stent | 0.54 (0.37-0.80) | 0.002 | 0.61 (0.41-0.91) | 0.01 |
| Oral anticoagulation | 1.19 (0.81-1.74) | 0.37 | 1.09 (0.74-1.60) | 0.67 |
| Statin | 0.61 (0.42-0.90) | 0.01 | 0.79 (0.53-1.17) | 0.24 |
| No SMuRFs group | 1.24 (0.63-2.41) | 0.54 | 1.18 (0.60-2.32) | 0.63 |
| Active cancer group | 3.59 (2.40-5.37) | <0.001 | 3.04 (2.00-4.62) | <0.001 |
| CSIDs group | 1.67 (1.02-2.75) | 0.04 | 1.91 (1.15-3.17) | 0.01 |